Key Takeaways
- Remicade (infliximab) is a biologic infusion therapy that targets the inflammation behind Crohn's disease, helping patients move toward remission when other treatments haven't worked.
- Most patients notice some improvement in symptoms within the first two weeks, but full benefit typically takes 6 to 14 weeks as the medication completes its initial loading doses.
- Response time depends on disease severity, how long Crohn's has been active, and whether the body develops antibodies to the medication over time.
- Patience matters, but so does communication. If symptoms aren't improving on the expected timeline, your gastroenterologist can adjust dosing, frequency, or consider alternatives.
- The Denver Arthritis Clinic, with locations in Lowry, Denver, and Lone Tree, CO, provides expert biologic infusion care through The Infusion Center at Denver Arthritis Clinic. Talk to your gastroenterologist about a referral to The Infusion Center at Denver Arthritis Clinic for infusion therapy for Crohn's disease.
What Is Remicade and How Does It Work for Crohn's Disease?
Remicade is the brand name for infliximab, a biologic medication delivered by intravenous infusion. It belongs to a class of drugs called TNF inhibitors, which block a protein called tumor necrosis factor-alpha. In Crohn's disease, TNF drives much of the inflammation that damages the digestive tract, causing pain, diarrhea, fatigue, and the long list of symptoms that make daily life difficult.
By neutralizing TNF, Remicade calms the immune response and gives inflamed tissue a chance to heal. According to the Crohn's & Colitis Foundation, biologics like infliximab are typically used for moderate to severe Crohn's, for patients who haven't responded to other treatments, or when the disease is causing fistulas or complications.
What is Remicade used for beyond Crohn's? The same medication is approved for ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, and psoriatic arthritis, which is why specialty infusion centers see a wide range of patients receiving it.
The Realistic Remicade Treatment Timeline
Remicade isn't a quick-fix medication. The dosing schedule is designed to build up the medication in your system, hold it steady, and then maintain it long-term.
Loading Doses: Weeks 0, 2, and 6
The first three infusions are called the 'loading' or 'induction' phase. They are given at weeks 0, 2, and 6, and they're meant to bring inflammation under control as quickly as the medication safely allows.
- Week 0: First infusion. Some patients feel a small improvement within days, but most don't.
- Week 2: Second infusion. Roughly half of patients begin to notice meaningful symptom relief, particularly in urgency, frequency of bowel movements, and abdominal pain.
- Week 6: Third infusion. Most patients who are going to respond have shown clear improvement by this point.
Maintenance Phase: Every 8 Weeks
After the loading doses, Remicade is typically given every 8 weeks. Some patients need more frequent dosing (every 4 to 6 weeks) or a higher dose if their symptoms return between infusions.
When Patients Typically Feel Their Best
Most Crohn's patients on Remicade reach their best response somewhere between weeks 6 and 14. A landmark study published by the National Institutes of Health (the ACCENT I trial) found that approximately 58 percent of patients had a clinical response by week 2, with continued improvement over the following weeks for those on maintenance therapy.
Signs Remicade Is Working
Improvement on Remicade is usually gradual, so it helps to know what to look for. Positive signs include:
- Less abdominal pain and cramping.
- Fewer trips to the bathroom each day.
- Less urgency and improved bowel control.
- More formed stools and less blood or mucus.
- Better energy and less fatigue.
- Improved appetite and steady weight.
- Healing of fistulas or perianal disease (this can take longer, often 14 weeks or more).
- Lower inflammation markers on lab work, including CRP and fecal calprotectin.
You don't need to see all of these to know the medication is working. Even modest, steady improvement in two or three areas is a meaningful sign.
Signs Remicade May Not Be Working as Expected
Not every patient responds to Remicade, and some who respond initially lose response over time. Watch for:
- No noticeable improvement after the third infusion (week 6).
- Symptoms that improve and then return between infusions.
- New or worsening symptoms despite being on treatment.
- Rising inflammation markers on lab tests.
- Needing steroids again to control flares.
These don't necessarily mean Remicade has failed. Often, your gastroenterologist can check drug levels and antibody status, adjust the dose or frequency, or combine Remicade with another medication. Loss of response is a known issue with all TNF inhibitors, not a sign that you've done anything wrong.
Factors That Affect Response Time
Several factors influence how quickly and how well Remicade works for Crohn's disease.
| Factor | Colonoscopy |
|---|---|
| Disease severity | More severe inflammation often takes longer to fully respond |
| Disease duration | Long-standing Crohn's with scarring may respond less completely than newer disease |
| Concurrent medications | Combining with an immunomodulator (like azathioprine or methotrexate) can improve and prolong response |
| Body weight and dosing | Some patients need higher per-kilogram dosing for full benefit |
| Antibody development | Roughly 10 to 30 percent of patients develop antibodies that reduce effectiveness |
| Smoking | Smoking is linked to worse response to all Crohn's treatments |
When to Contact Your Gastroenterologist About Ongoing Symptoms
The Crohn's care team expects patients to check in throughout the loading phase and beyond. Reach out to your gastroenterologist if you experience any of the following:
- No improvement by week 6.
- Worsening symptoms at any point.
- Symptoms returning earlier and earlier between infusions.
- New symptoms like joint pain, eye inflammation, or skin rashes.
- Concerns about infections, fevers, or unusual fatigue.
Early communication often leads to simple adjustments (dose, frequency, drug levels) that get treatment back on track.
Schedule Your Crohn's Infusion Therapy at The Denver Arthritis Clinic
Remicade can be a meaningful turning point in Crohn's care, but the timeline takes patience and the right support team along the way. Tracking your symptoms, staying consistent with the infusion schedule, and keeping open communication with your gastroenterology team gives you the best chance of a full response.
If you have Crohn's disease and your treatment plan includes biologic infusion therapy, talk to your gastroenterologist about a referral to The Infusion Center at Denver Arthritis Clinic for infusion therapy for Crohn's. Our experienced rheumatology nursing team delivers Remicade and other biologics in a comfortable, in-office setting at our Lowry, Denver, and Lone Tree, CO locations. Request an appointment or learn more at The Denver Arthritis Clinic.
Frequently Asked Questions
How long does Remicade take to work for Crohn's disease?
Most patients begin to feel some improvement within the first two weeks after their first infusion, with continued benefit through weeks 6 to 14. Full response usually requires completing the loading doses at weeks 0, 2, and 6, and then continuing maintenance every 8 weeks.
What is Remicade used for besides Crohn's disease?
In addition to Crohn's, Remicade is approved to treat ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. The same biologic infusion is used across these conditions because TNF-alpha drives inflammation in all of them.
Where can I find infusion therapy near me for Crohn's disease in Denver?
The Infusion Center at Denver Arthritis Clinic provides biologic infusions including Remicade, Entyvio, Stelara, and others at Lowry, Denver, and Lone Tree, CO. A gastroenterologist referral is typically needed to begin Crohn's-specific infusion therapy.
Can Remicade stop working over time?
Yes. Roughly 10 to 30 percent of patients develop antibodies to infliximab that reduce its effectiveness, and others may lose response without antibodies. Your gastroenterologist can check drug levels and antibody status, then adjust dose, frequency, or switch medications if needed.
What should I do if Remicade isn't helping after six weeks?
Contact your gastroenterologist. They may order drug-level testing, increase your dose, shorten the interval between infusions, add an immunomodulator, or consider a different biologic. Lack of response by week 6 is a common reason for treatment adjustment, not a reason to give up on infusion therapy.
